Shredded cheese sold at Walmart and other stores recalled due to metal

The FDA said more than 1 million bags of shredded cheese sold at major retailers are being recalled because they may contain metal fragments.

• 21H ago

12 ex-FDA leaders criticize claims made by agency's current vaccine chief

The former officials said the FDA's plans to revamp how certain life-saving vaccines are handled would "disadvantage the people the FDA exists to protect, including millions of Americans at high risk from serious infections."

• Dec 3

U.S. not recognizing World AIDS Day this year

Monday is World AIDS Day. It has been recognized globally since 1988, but this year, the U.S. government is not commemorating it for the first time. CBS News medical contributor Dr. Céline Gounder joins with more.

• Dec 1
• 04:15

Debate over COVID vaccine approval standards

The FDA's vaccine chief says the agency plans to tighten approval standards for COVID-19 vaccines, citing concerns about potential risks for children. In a leaked memo, Dr. Vinay Prasad says a review of records links 10 children's deaths to the COVID vaccine. He did not provide data to support the claim. CBS News medical contributor Dr. Celine Gounder explains what to know.

• Dec 1
• 03:24

FDA official claims link between COVID-19 vaccines and pediatric deaths

Dr. Vinay Prasad, the director of the FDA's vaccine division, did not provide data to back the claim in a memo sent to staff.

• Nov 29

FDA's plan to boost cheaper copycat drugs could stall at patent office

The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the opposite direction.

• Nov 14

Doctor reacts to FDA warning label removal

The FDA says it will remove the "black box" warning labels on many hormone therapy drugs used to treat menopause and perimenopause. Dr. Tami Rowen, an associate professor at the University of California, San Francisco, joins to break down the announcement.

• Nov 10
• 04:33

Changes to menopause hormone therapy warnings

The Food and Drug Administration says it is removing safety warnings for many hormone therapy drugs prescribed to ease symptoms of menopause and perimenopause. Dr. Erika Schwartz, founder of the Evolved Science medical group in New York City, joins with her reaction.

• Nov 10
• 03:26

Changes to menopause drug warning labels

The Food and Drug Administration is removing "black box" warnings on hormone therapy drugs used to treat menopause, Health and Human Services Secretary Robert F. Kennedy Jr. announced on Monday. CBS News' Shanelle Kaul has more.

• Nov 10
• 03:34

FDA chief on change to hormone therapy labels

FDA commissioner Dr. Marty Makary joins "CBS Mornings" to discuss the agency's announcement Thursday that boxed warnings will be removed from many estrogen products used for hormone therapy, a treatment that helps alleviate the symptoms of menopause.

• Nov 10
• 05:33

FDA's top drug regulator quits as agency officials probe actions

The FDA's top drug regulator, Dr. George Tidmarsh, quit after federal officials began reviewing "serious concerns about his personal conduct," a government spokesperson said.

• Nov 3

FDA says these 18 brands of cinnamon contain elevated levels of lead

The FDA has identified 18 brands of ground cinnamon with elevated levels of lead that it says should be thrown out. Here's what to know.

• Oct 31

Doctor explains new non-hormonal menopause drug

The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a non-hormonal option for treating hot flashes, common during menopause. Dr. Celine Gounder explains.

• Oct 27
• 01:36

FDA approves non-hormonal menopause drug

The Food and Drug Administration has approved a new non-hormonal pill to treat hot flashes and night sweats brought on by menopause. Dr. Joann Pinkerton, professor of obstetrics and gynecology at the University of Virginia Health System and one of the drug's trial investigators, joins CBS News to explain how the medication works.

• Oct 27
• 03:03

FDA approves new menopause drug without hormones. Here's what to know.

The U.S. Food and Drug Administration has approved Lynkuet, a new medication that does not contain hormones to treat hot flashes due to menopause.

• Oct 27

Trace radiation found at farm after Cesium-tainted food detected in U.S.

An investigation sparked by Cesium-137-tainted spices and shrimp in the U.S. has detected trace radiation at a clove farm in Indonesia.

• Oct 14

Kroger recalls deli pasta salads due to possible listeria contamination

The Kroger Company's recall follows another FDA recall announcement last week of possibly contaminated pasta.

• Oct 5

FDA head on Trump-Pfizer deal to lower drug costs

President Trump announced plans to reduce the prices of prescription drugs. Americans will be able to buy them at discount on a "TrumpRx" website that rolls out next year. Nikki Battiste spoke to FDA Commissioner Marty Makary.

• Oct 2
• 02:34

Walmart to remove synthetic dyes, other food additives from store brands

Walmart says it will eliminate preservatives, plasticizers and other chemicals from its house food brands by 2027.

• Oct 1

Kennedy says FDA is reviewing safety of abortion pill mifepristone

Conservatives have criticized the abortion medication, particularly after it became available through telehealth.

• Sep 26

Dr. Oz says "of course" pregnant women should take Tylenol if a doctor says so

President Trump's announcement this week about an alleged link between Tylenol and autism has drawn pushback from medical experts.

• Sep 26

What to know about FDA review of mifepristone

Health Secretary Robert F. Kennedy Jr. has launched an FDA review of mifepristone, the drug used in two-thirds of all abortions. Abortion rights advocates are worried the FDA could restrict access to the pill even in states where abortion is legal. Dr. Celine Gounder explains.

• Sep 25
• 02:12

Tylenol-autism claim gets major pushback

President Trump's warning about Tylenol use during pregnancy, claiming it's linked with an increased risk of autism, rattled the medical community and is getting major pushback. Jericka Duncan has more.

• Sep 23
• 02:38

FDA seeks to abandon expert reviews of new drugs

The Food and Drug Administration is looking to shift away from policies dating back decades of having outside experts and panels review new drug applications. These external committees have been used since the 1970s in order to better advise health officials facing difficult decisions. Arthur Allen, senior correspondent for KFF Health News, joined CBS News to discuss.

• Sep 15
• 02:37

Under Trump, FDA seeks to abandon expert reviews of new drugs

Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn't make sense, former officials said.

• Sep 12

Show More